STOCK TITAN

UnitedHealth (UNH) director receives 206 deferred stock units as quarterly pay

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director John H. Noseworthy received a grant of 206 shares of common stock in the form of deferred stock units as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 7,616 shares.

Positive

  • None.

Negative

  • None.
Insider Noseworthy John H
Role null
Type Security Shares Price Value
Grant/Award Common Stock 206 $0.00 --
Holdings After Transaction: Common Stock — 7,616 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Deferred stock units granted 206 shares Quarterly director compensation grant on 2026-07-01
Holdings after transaction 7,616 shares Total common stock directly held after grant
Grant price per share $0.00 per share Compensation award, not a market purchase
Transaction code A (Grant, award, or other acquisition) Non-derivative acquisition reported on Form 4
deferred stock units financial
"Represents deferred stock units that are granted as regular quarterly compensation for service as a director"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
regular quarterly compensation financial
"deferred stock units that are granted as regular quarterly compensation for service as a director"
immediately vested financial
"Deferred stock units are immediately vested, but must be retained by the director"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did UNH director John H. Noseworthy report?

John H. Noseworthy reported receiving 206 shares of UNITEDHEALTH GROUP INC common stock as deferred stock units. This was a regular quarterly compensation grant for his service as a director, not an open-market share purchase or sale.

How many UNITEDHEALTH GROUP INC shares does John H. Noseworthy hold after this Form 4?

After the grant, John H. Noseworthy holds 7,616 shares of UNITEDHEALTH GROUP INC common stock directly. These holdings include the 206 deferred stock units awarded as regular quarterly compensation for his ongoing service on the company’s Board of Directors.

Are the deferred stock units granted to UNH director John H. Noseworthy vested?

The deferred stock units granted to John H. Noseworthy are immediately vested upon grant. However, he must retain these units until he completes his service on the UNITEDHEALTH GROUP INC Board, limiting his ability to access them before leaving the Board.

Is John H. Noseworthy’s Form 4 transaction a stock purchase or sale of UNH shares?

The Form 4 transaction is neither a market purchase nor a sale. It reflects a grant of 206 deferred stock units as regular quarterly director compensation, with no price paid per share and no open-market trading involved in this reported transaction.

Why did UNITEDHEALTH GROUP INC grant 206 deferred stock units to John H. Noseworthy?

UNITEDHEALTH GROUP INC granted 206 deferred stock units to John H. Noseworthy as regular quarterly compensation for his Board service. This aligns director pay with company equity performance, while requiring the units to be held until his Board service is completed.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Noseworthy John H

(Last)(First)(Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MINNESOTA 55344

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A206(1)A$07,616D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for John H. Noseworthy M.D.07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)